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Abstract 
Background 
We have previously reported that hirsein A inhibits melanogenesis in B16 melanoma cells by 
downregulating the Mitf gene expression.   
 
Objective  
In this study, microarray was employed to determined the transcriptional response of B16 cells to 
hirsein A (HA) treatment and to find out the mechanism underlying Mitf downregulation. 
   
Methods 
DNA microarray, spotted with 265 genes for melanogenesis and signal transduction, was 
performed using the total RNA isolated from B16 cells treated with HA. Validation of the results 
was done using real-time PCR. In addition, real-time PCR using primers for Mda-7 gene and F-
actin staining were performed. Transfection experiments were performed to knockdown the 
expression of the Mc1r gene to evaluate its role in the cell morphological change observed.  
 
Results 
     As expected, the expressions of the Mitf-regulated melanosome transport genes and the Mc1r 
gene were downregulated.  Furthermore, the expressions of the MAPK pathway intermediates 
were either up- or downregulated. Genes associated with cell differentiation, such as Gadd45b,  
were upregulated and prompted us to determine the expression of the Il-24 (Mda-7) gene using 
real-time PCR.  There was an increase in the Mda-7 mRNA expression in B16 and HMV-II 
melanoma cells, and in human melanocytes.  To better visualize the cell morphology, F-actin 
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staining was performed and the results showed an increase in the dendrite outgrowth in HA-
treated cells.  Silencing the Mc1r gene did not cause a change in the B16 cell morphology 
observed in cells treated with HA. 
 
Conclusion 
     This study demonstrated that HA downregulates Mitf gene expression by regulating the 
expressions of the MAPK signaling pathway intermediates. In addition, the inhibited Mc1r gene 
expression also contributed to the overall Mitf downregulation but do not play a role in the 
observed change in B16 cell morphology. HA surprisingly can regulate genes associated with 
differentiating cells (Mda-7) suggesting a role for HA  in the melanoma cell differentiation 
induction. While the exact molecular mechanism by which HA promotes cell differentiation 
remain to be determined, it is clear that HA can downregulate Mitf expression and promote cell 
differentiation and has the potential to be used in the development of therapy for melanoma. 
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Abbreviations: HA, hirsein A; B16 cells, B16 murine melanoma cells; HMV-II, HMV-II human 
melanoma cells;  HEMs, human epithelial melanocyte; α- MSH, alpha- melanocyte stimulating 
hormone; Rp-cAMPS,  adenosine-3,5'-cyclic monophosphorothioate, Rp-isomer; Mitf, 
microphthalmia-associated transcription factor; Mc1r, melanocortin 1 receptor; Rab27a,  
RAB27A, member RAS oncogene family; Sorbs3, sorbin and SH3 domain containing 3; Mlph, 
melanophilin; Ldb1, LIM domain binding 1; Myo5a , myosin VA; Ppap2b,  phosphatidic acid 
phosphatase type 2B; Gadd45b, growth arrest and DNA-damage-inducible 45 beta; Pxn, 
Paxillin; Map2k3, mitogen-activated protein kinase; Wisp1,WNT1 inducible signaling pathway 
protein 1; Prkx, protein kinase, X-linked; siRNA, short interfering RNA. 
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Introduction  
Pigmentation in humans depends on the amount and deposition of melanin in the skin, 
which relies on the biosynthesis of melanin or melanogenesis within the membrane-bound 
organelles termed melanosomes [1-2]. Melanogenesis involves the conversion of tyrosine to 
melanin through a series of enzymatic and spontaneous reactions mediated by the enzymes 
tyrosinase (Tyr), tyrosinase-related protein 1 (Trp1) and tyrosinase-related protein 2 (Trp2) [3-6], 
the expression of which is regulated by the microphthalmia- associated transcription factor (Mitf) 
gene [7]. Melanin is necessary for the prevention of cancer caused by UV irradiation and its 
regulation is important in addressing a number of diseases and cosmetic problems [8].   
     In controlling melanogenesis, knowledge of the function and regulation of the  Mitf gene is 
very important because it is also the gene responsible for the development, function, and survival 
of melanocytes [9] and melanoma cells [10]. On the other hand, Mitf promotes malignant 
behavior as observed in some human melanomas and human clear cell sarcoma wherein Mitf has 
been demonstrated as an amplified oncogene and an understanding of its function and associated 
pathways have been suggested to help shed light on improving therapeutic approaches for 
melanoma [10]. More importantly, Mitf has become a molecular target for the management of 
melanoma [11].  
     The cAMP/protein kinase A (PKA) pathway is one of the most important signaling pathways 
that can induce melanogenesis [12-13]. Cyclic AMP, through the activation of PKA and cAMP-
responsive element binding protein 1 transcription factors, upregulates the expression of Mitf 
[14]. The production of the melanogenic enzymes (tyrosinase, TRP-1, and DCT) is controlled by 
Mitf at the mRNA level [15]. cAMP can promote the transcription of Mitf through a classical 
cAMP response element and this has been demonstrated by using a dominant-negative mutant of 
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Mitf which showed that Mitf is required for the cAMP effect on tyrosinase promoter  [14]. 
In melanocytes, the expressions of the Tyr, Trp1, Dct genes, and the melanosome 
transport associated genes Rab27a, Myo5a, and Mlph are regulated by the Mitf [16-20].  
Melanosomes are transported first within the melanocyte, from around the nucleus and from the 
tips of the dendrites of the melanocytes to keratinocytes for effective pigmentation[21].  Pigment 
cell dendricity or cell differentiation is usually associated with an increase in melanin content to 
facilitate the transfer of melanin inside the melanosome, from melanocytes to neighboring 
keratinocytes [21]. However, Mitf  which regulates melanogenesis is found to be highly 
expressed in most primary melanomas [22] and reinforces the idea that the origin of malignant 
melanoma is linked to the melanocyte lineage, thus making Mitf important in melanoma cell 
survival [6]. The signaling pathways that regulate Mitf are the same pathways that are relevant in 
melanoma tumorigenesis and progression [23, 24]. The use of cell differentiation agents has been 
suggested as a potentially less toxic approach to cancer therapy or „differentiation therapy‟ [25, 
26].  Recently, several groups of researchers focus on the anticancer gene therapeutic potential of 
the melanoma differentiation-associated gene-7 (mda-7) [27].  Mda-7 belongs to the IL-10 
family of cytokines and has therefore been re-designated IL-24. Mda-7 is a molecule whose 
expression is elevated in terminally differentiated human melanoma cells and can differentiate 
between cancer cells and normal cells [27].   
Daphnane-type diterpenes have been used to investigate processes such as apoptosis, 
neutrophism and tumor promotion [28], and have shown significant MET tyrosine kinase 
inhibition activity [29].  Recently, we reported that hirsein A (HA) from Thymelaea hirsuta L. 
can inhibit melanogenesis by decreasing the tyrosinase enzyme mRNA expression through the 
downregulation of the Mitf gene expression [30].  Furthermore, HA treatment also induced an 
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increase in the dendrite outgrowth of B16 cells.  Although the effect of HA on Mitf and 
melanogenic enzymes‟ mRNA expressions have been reported, the effect of HA on other genes 
related to melanogenesis, the underlying cause of Mitf gene inhibition and B16 cell 
morphological change are yet unknown. 
     In this study, microarray analysis was used and the results helped identify the targets of HA in 
B16 melanoma cells to understand the underlying reason for the inhibition of the Mitf gene 
expression.  In addition, the data generated in this study will give an insight into the 
morphological change observed.   
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Materials and Methods 
Cell culture and treatment method 
     B16 murine melanoma cells were purchased from the Riken Cell Bank in Tsukuba, Japan, 
and maintained as a monolayer culture in DMEM (Sigma, St Louis, MO, USA) supplemented 
with 10% fetal bovine serum or FBS  (Sigma), 50 U⁄ ml penicillin and 50 µg/ml streptomycin 
(Cambrex, East Rutherford, NJ, USA).  Human melanoma HMV-II cells were maintained in 
Ham F12 (Gibco) supplemented with 10% FBS.  Both cell lines were incubated at 37
o
C in a 95% 
air and 5% CO2 incubator.  Human epidermal melanocytes or HEM (Cryopreserved HEM, Cat. 
104-05n), melanocyte growth medium (Cat. 135-5001) and trypsin/EDTA solution (Subculture 
Reagent Kit, Cat. 070-100) were purchased from Cell Applications, Inc.
TM
 (San Diego, CA, 
USA).  Cells were subcultured in 75 cm flasks (Corning, Inc, New York, NY, USA) at 37
o
C in a 
5% CO2 humidified incubator, and expanded for at least five passages.  The medium was 
changed twice a week and subcultured when they are about 80% confluent. For total RNA 
extraction of B16 or HMV-II cells, cells at a density of 3 × 10
6 
cells per petri dish were seeded 
onto 100-mm dishes and cultivated using the method described above.  After overnight 
incubation, the medium was then replaced with 1 µM hirsein A (HA)-containing medium 
followed by incubation for 4 h prior to the extraction of total protein or total RNA.  For RNA 
isolation from HEM, cells were seeded into 10-cm culture plates and incubated for 24 hours, 
after which, HEM were treated with or without HA and incubated for an additional 4 h prior to 
total RNA isolation.     HA was isolated as described previously [31] while Rp-cAMPS 
(adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer) was obtained from SantaCruz 
Biotechnology  (Santa Cruz, CA) and the α-MSH (alpha melanocyte-stimulating hormone) from 
Sigma,( St Louis, MO, USA ).  Rp-cAMPS was used as a positive control for the inhibition  of 
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the cAMP-dependent protein kinase (PKA) [32]while α-MSH was used to activate the cAMP 
pathway [ 33]. 
 
Total RNA Extraction 
Total RNA was extracted using ISOGEN kit (Nippon Gene, Tokyo, Japan) following the 
manufacturer‟s instructions and quantified using a Nanodrop 2000 spectrophotometer (Nanodrop 
Technologies).  Reverse transcription polymerase chain reaction (RT-PCR) was carried out with 
the Superscript III reverse transcriptase kit (Invitrogen, Carlsbad, CA, USA) following the 
manufacturer‟s instructions, using 1 µg of total RNA.  Three different RNA sample sets were 
used to ensure that the confirmation of the gene expression patterns by real-time PCR and 
employed a different sample set than those used for DNA microarray.   
 
DNA Microarrays 
To determine the gene expression changes in B16 cells treated with HA, DNA chips 
loaded with 265 genes prepared by GenoPal™ microarray (Mitsubishi Rayon Co., Ltd, Tokyo, 
Japan), were used to determine the effect on genes significant for melanogenesis, membrane-
bound receptors, tyrosine kinase regulation, melanosome transport, and other cell signal 
regulation-related genes (including the housekeeping and negative control genes). aRNA was 
synthesized from total RNA previously extracted from B16 cells following the GenoPal protocol.  
Briefly, RNA was amplified using the MessageAmpII biotin-enhanced amplification kit (Applied 
Biosystems Japan, Tokyo, Japan), according to the manufacturer‟s instructions, and column 
purified.  Biotinylated aRNA (5 µg) was fragmented using fragmentation reagents (Applied 
Biosystems Japan) and then incubated at 94°C for 7.5 min. Hybridization was carried out in 150 
11 
 
µL of hybridization buffer [0.12 M Tris-HCl/0.12 M NaCl/0.05% Tween-20] and 5 µg of 
fragmented biotinylated aRNA at 65°C overnight.  After hybridization, the DNA microarray was 
washed twice in 0.12 M Tris-HCl/0.12 M NaCl/0.05% Tween-20 at 65 °C for 20 min followed 
by washing in 0.12 M Tris-HCl/0.12 M NaCl for 10 min.  The DNA microarray was then labeled 
with streptavidin-Cy5 (GE Healthcare Bio-Science KK, Tokyo, Japan).  The fluorescent-labeled 
DNA microarray was washed for 5 min four times in 0.12 M Tris-HCl/0.12 M NaCl/0.05% 
Tween-20 at room temperature.  Hybridization signal acquisition was performed using a DNA 
microarray reader adopting multibeam excitation technology (Yokogawa Electric Co., Tokyo, 
Japan). The DNA microarrays were scanned at multiple exposure times ranging from 0.1 to 40 s.  
Then, the intensity values with the best exposure condition for each spot were selected.  
 
Analysis of the microarray data 
Detected hybridization signals that were higher than the background intensity (BI) were 
regarded as „positive‟ and the relative amount of each transcript was normalized to the amount of 
the Actb, Arbp, GAPDH, GUSB, and PGK1 transcripts in each sample. Transcripts were 
considered significantly altered when the average log of the ratio (between treated and untreated 
control) calculated from 3 replicates per treatment was  ≤ -0.5 for the downregulated genes and  
≥ 0.5  for the upregulated genes. The log of the ratio between the treated sample and control was 
then subjected to hierarchical clustering using Euclidean distance and average linkage algorithm 
of the TIGR Mev version 3.0.3 software (The Institute for Genomic Research, MD, USA) [33] 
for visualization of the response to HA,  Rp-cAMPS or α-MSH  treatment.  Gene expression 
ratios were displayed in green and red for decreased and increased gene expression, respectively,   
compared to untreated control. 
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Quantitative real-time PCR analysis  
Quantitative real-time polymerase chain reaction (rt-PCR) analysis was performed with a 
7500 Fast Real-Time PCR system using TaqMan Universal PCR mix and TaqMan probes 
(Applied Biosystems, Foster City, CA, USA)  to quantify the expression of the following genes: 
Mitf, Mc1r, Myo5a, Myo7a, Rab27a, Mlph, Sorbs3, Ppap2b, Gadd45b, Map2k3, Wisp1, and 
Prkx. Gapdh was used as a housekeeping gene.  Rt-PCR reactions were run on ABI 7500 Fast 
(Applied Biosystems) with the following thermal cycling protocol: 95 
o
C for 10 min followed by 
40 cycles of 95 
o
C for 15 s and 60 
o
C for 1 min.  The Assay ID of the primers (Applied 
Biosystems) used for Rt-PCR are the following  :  Mitf – Mm00434954_m1, Mc1r - 
Mm00434851_s1,  Rab27a- Mm00469997_m1, Sorbs3- Mm00488174_m1, MyoVa - 
Mm00487823_m1, MyoVIIa - Mm01274015_m1, Mlph – Mm00453498_m1, Ppap2b- 
Mm00504516_m1 , Gadd45b - Mm00435123_m1,  Map2k3 – Mm00435950_m1, Prkx –
Mm00457493_m1, Wisp1- Mm00457574_m1, Pxn – Mm00448533_m1, Il24 – 
Mm00474102_m, 1 and Gapdh – Mm99999915_g1. Data were analyzed using 7500 Fast System 
SDS Software 1.3.1. (Applied Biosystems). 
 
F-actin staining 
The distribution of F-actin was visualized by staining B16 cells with phalloidin-
rhodamine.  B16 cells were subcultured onto four-well chamber slides (Nunc, Rochester, NY, 
USA) at a density of 4 × 10
4
 cells per well.  After overnight incubation, the medium was 
replaced with 1 µM HA- or 0.2 µM α-MSH-containing medium and incubated for an additional 
24 h.  After removing the medium, the cells were washed with PBS and fixed with 3.7% 
formaldehyde for 5 min, washed and permeabilized with 0.2% Triton X-100 in PBS for 5 min, 
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and then washed with PBS thrice.  The cells were then stained with rhodamine-phalloidin 
(Cytoskeleton Inc., Denver, CO, USA) (70 nM) and incubated for 30 min at room temperature in 
the dark, after which the cells were again washed three times with PBS.  Mounting reagent 
containing DAPI (Vector Laboratories, Inc., Burlingame, CA, USA) was added and fluorescent 
signals were detected and photographed using a Leica DMI-4000B fluorescence microscope and 
a Leica DFC300FX CCD camera (Leica, Wetzlar, Germany).  The images were analyzed using a 
light microscope system (Leica).  
 
Transfection experiments 
To determine if the observed change in cell morphology was due to the inhibition of the 
Mc1r gene expression, transfection experiments using Lipofectamine RNAiMAX (Invitrogen) 
complexed with sequence-specific Silencer Select siRNA that targets murine Mc1r mRNA 
purchased from Ambion (Austin, TX) (sense: 5'-CCCUCUUUAUCACCUACUAtt-3', anti-
sense: 5'-UAGUAGGUGAUAAAGAGGGtg-3') was performed following the manufacturer‟s 
instructions.  B16 cells were seeded into 6-well plates at a density of 1×10
5
 cells per well, 
incubated for 24 prior to transfection with Negative control siRNA or Mc1r siRNA (at a final 
concentration of 5 nM). After 24 h of incubation, control cells were left untreated or treated with 
200 nM α-MSH or 1 µM hirsein A (HA) and incubated further for 4 h prior  to RNA extraction.  
 
 
Statistical evaluation  
Mean values ± SEM were calculated; statistical analyses of the results were performed 
using Student‟s t-test to determine the significance of results versus that of the control.  A value 
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of p< 0.05 was considered significant. 
Results 
Transcriptional profile of the hirsein A-treated B16 cells 
To shed light on the molecular mechanism of the effect of hirsein (HA) treatment on the genes 
that are important for pigmentation and intracellular signaling pathways, the gene expression 
profile of B16 melanoma cells, cultured in the presence or absence of HA, Rp-cAMPS or α-MSH, 
was analyzed using DNA microarray. Gene expressions, expressed as log2,  were decreased for 
Mitf and Mc1r, by about 2- to 3-fold, respectively, while the expressions of the melanosome 
transport-associated genes (Rab27a and Mlph), were decreased 2-fold (Table 1). In addition, 
Sorbs3, a gene involved in cell adhesion, negative regulation of transcription from RNA 
polymerase II promoter,  and positive regulation of MAPKKK cascade, was also significantly 
downregulated by HA treatment but not with Rp-cAMPS or α-MSH treatment.  Rp-cAMPS or α-
MSH caused a slight increase in Sorbs3 gene expression. Furthermore, HA treatment 
downregulated the expressions of the following genes: Mreg (functions in developmental or 
melanocyte differentiation), Agt (functions in G-protein coupled receptor protein signaling 
pathway, and activation of phospholipase C activity), Map2k5 (functions in MAPKKK cascade, 
positive regulation of cell growth and epithelial cell proliferation), Prkar2b (functions in cell 
proliferation, regulation of protein kinase activity and protein phosphorylation, signal 
transduction).  The downregulated (11) and upregulated (22) genes  were subjected to 
hierarchical clustering to determine the relationship between genes (Figure 1). From among these 
33 genes modulated by HA, α-MSH and Rp-cAMPS treatments had an influence on the 
expressions of  22 and 25 genes, respectively.  Treatment with HA, but not with Rp-cAMPS or α-
MSH, caused a two- or three-fold increase in the expressions of the following genes: Ppap2b, 
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Pxn, Gadd45b, Wisp1, Mapkapk3 and Ppm1.  The gene tree generated by hierarchical clustering, 
yielded two main groups that represent the HA-upregulated  and the HA-downregulated genes, 
with two and three subgroups each, respectively.   
 
Differentially expressed genes validated using real-time PCR  
The relative changes in the expression of genes, initially determined by microarray as 
expressed differentially following hirsein treatment,  were validated using the TaqMan gene 
expression system and presented in Figures 2a (Mitf and Mc1r genes), 2b (Rab27a, Mlph, and 
MyoVa or melanosome transport-associated genes), Figure 2c (Sorbs3), and Figure 2d (six of the 
upregulated genes). Results show that the mRNA levels for Mitf and Mc1r gene expressions 
were decreased significantly (p<0.05). In the same manner, the expressions of the melanosome 
transport associated genes were reduced by 50% compared to that of the control. Highly 
significant increases in the expressions of the Ppap2b, Gadd45b, and the Map2k3 genes were 
observed. Ppap2b and Gadd45b genes were increased by 800% and 200%, respectively. The 
results of the real-time PCR analysis showed changes in genes‟ expressions which are consistent 
with the microarray data.   
 
Enhanced Mda-7 gene expression confirmed the cell differentiation effects of HA 
The increase in the expressions of the cell differentiation-associated genes, Ppap2b and 
Gadd45b prompted us to determine if the observed change in morphology may be due to 
differentiation by determining the mRNA expression of the melanoma differentiation-associated 
gene 7 (Mda-7) gene in B16 cells.  The expression of the Mda-7 gene in HA-treated murine 
melanoma cells, human melanoma, and human melanocytes were compared by determining the 
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expression of the Mda-7 gene in B16 cells, HMV-II cells, and HEMs using real-time PCR (Fig. 
3).  Compared with the control, results show that treatment with HA or α-MSH treatment 
promoted a significant increase in Mda-7 gene expression in B16 cells. In HMV-II cells however, 
only HA was able to increase the Mda-7 gene expression.  Both HA and α-MSH significantly 
increased the expression of Mda-7 gene in  human melanocytes.  
 
Staining with rhodamine-phalloidin revealed an increase in F-actin polymerization 
To determine if the increase in dendricity after HA treatment is due to an increase in the 
F-actin polymerization, we determined the expression of F-actin by staining B16 cells, treated 
with HA or α-MSH, with rhodamine-phalloidin.  Results showed that HA-treated cells had more 
phalloidin-labeled F-actin (Fig. 4) than the control or α-MSH-treated cells. HA-treated cells had 
dendritic extensions not observed in control or MSH-treated cells due to a changed F-actin 
polymerization.  It can also be noted that like melanocytes, HA-treated cells appeared to be 
scattered, and not clumped together as observed in control cells, similar to that of the 
melanocytes in the skin.   
 
Silencing the Mc1r gene expression did not cause the change in cell morphology  
To determine if the change in morphology was caused by the inhibition of the Mc1r gene 
expression, transfection experiments were performed.  Cells that were transfected with Mc1r 
siRNA and negative control siRNA exhibited a change in cell morphology (Fig. 5a).  Verifying 
the gene expressions using real-time PCR revealed a significant increase and decrease in 
expression of Mc1r genes in Negative Control-transfected cells treated with α-MSH and HA 
respectively. Trasfection with Mc1r siRNA silenced the Mc1r gene expression and subsequent 
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treatment with α-MSH did not cause any increase in expression.  Treatment with HA, however, 
further decreased the expression of Mc1r gene (Fig. 5b).  To determine the effect of Mc1r 
knowckdown on Mitf mRNA expression, real-time PCR was also performed using specific 
primers for Mitf. Results showed that  in the same manner, negative control siRNA-transfected 
cells had significant increase in Mitf expression when treated with α-MSH and significant 
inhibition of expression when treated with HA (Figure 5c). Although transfection with Mc1r 
siRNA caused a decrease in Mitf expression, its expression was not completely inhibited (25%). 
Treatment with α-MSH did not increase the Mitf expression more than that of the control. 
Treatment with HA further decreased (by 95%) the Mitf gene expression.  
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Discussion  
Our data showed that HA, a daphnane diterpene that has a melanogenesis inhibitory 
effect, elicited a unique transcriptional response in B16 melanoma cells. A few of the 
differentially expressed genes are those that have been reported to be regulated by the Mitf gene 
such as the melanosome transport genes Rab27a, MyoVa, and the Min Table 1), as well as genes 
associated with the MAPK pathway, MAPKKK cascade, phospholipid metabolic process, Wnt 
signaling pathway, and cell differentiation (Table 2).   
Hierarchical clustering comparing HA with α-MSH or Rp-cAMPS revealed two main 
clusters representing the HA-downregulated and the HA-upregulated genes (Fig. 1). The 
downregulated genes formed three subclusters – with the highly downregulated genes in the two 
subclusters (Mitf gene in one cluster and Mc1r, Mlph, Rab27a, and Sorbs3 genes in the second).  
Mitf is known to regulate the expressions of Rab27a, Mc1r [16, 35-36].  Clusters based on gene 
expression data are enriched for genes known to be involved in similar biological processes, 
implying that genes of unknown function may be involved in those same processes [37-38].  The 
obtained results, therefore, imply that  since Sorbs3 was clustered with the Mitf-regulated genes, 
the Mitf gene might have an influence on the expression of the Sorbs3 gene.  Although more tests 
are yet to be done to determine this relationship between Mitf and Sorbs3, it has been established 
that co-expression of genes of known function with poorly characterized or novel genes may 
provide a simple means of gaining leads to the functions of many genes for which information is 
not currently available [37].  Both Mc1r and Sorbs3  genes contain NF-kappaB1 and NF-kappaB 
in their upstream promoter region (www.genecards.org/, accessed 1 December 2010).  Reports 
on Sorbs3 gene associated it with cell adhesion and regulation of transcription from RNA 
polymerase II promoter, and its gene product,  vinexin, functions to enhance actin cytoskeletal 
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organization [39].  
     Genes that were downregulated by HA, such as Mitf and Mc1r, are significant for the 
inhibition of overall pigmentation.  One of the regulators of Mitf gene expression is the α-MSH.  
α-MSH activates melanocortin-1 receptor (Mc1r), resulting in a cAMP-mediated 
phosphorylation/activation of the CREB/ATF family of transcription factors to induce Mitf 
expression and regulate pigmentation in melanocytes [40]. Moreover, one of the most important 
signaling pathways found to induce melanogenesis is the cAMP/protein kinase A (PKA) 
pathway.  Mc1r promoter activity was induced approximately 5-fold in the presence of Mitf [41].  
Although it has been reported that the MC1R promoter may also be regulated by Mitf, raising the 
possibility that Mitf and Mc1R participate in a feedback loop [42], it has also been observed that 
in the presence of Mitf, the Mc1r promoter activity is induced 5-fold.  Cyclic AMP, through the 
activation of PKA and cAMP-responsive element binding protein 1 transcription factors, 
upregulates the expression of Mitf.  Elevated cAMP levels induce and increase Mitf levels, and 
therefore suggests that in principle, Mitf expression should be regulated by Mc1r. [43]. The time-
dependent decrease in the cellular cAMP content (data not shown) means that the decrease in 
cAMP content occurred in a later stage while the inhibition of Mitf gene expression occurred 4 h 
after treatment with HA suggesting that Mitf was inhibited not just by the decrease in the Mc1r 
gene expression but by also other signaling pathway such as the MAPK pathway. 
The four genes that were downregulated are Rab27a, MyoVA, Mlph, and Myo7a and 
these genes play an important role in melanosome transport.  Melanosomes develop and mature 
within melanocytes and their transport from the cell body of melanocytes to the tip of their 
dendrites requires two distinct motors, Rab27a [16-17] and myosinVa [17], while Slac2-
a/Melanophilin binds Rab27a and myoVa [18-19].  
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For the upregulated genes, the hierarchical clustering analysis produced two main clusters 
with the four highly expressed genes (Ppap2b, Gadd45b, Pxn, Map2k3) in one cluster, and other 
19 genes in the second cluster (Fig.1).  Ppap2b codes for protein that has lipid phosphatase 
activity and is involved in lipid phosphorylation, blood vessel development, and the Wnt 
signaling pathway among others.  The expression of Ppap2b gene is found to be enhanced by 
epidermal growth factor in Hela cells. [www.genecards.org/,accessed 1 Dec 2010]. Gadd45b 
gene is associated with the regulation of growth, apoptosis, and the cell cycle regulation. 
Gadd45b gene expression is known to be induced by NFκB (its promoter has three NFκB-
binding sites) [44].  
     Although most of the genes from same pathways were regulated in similar manner, MAPK 
signaling pathway genes were were up- or down-regulated. Map2k5 gene was downregulated but 
the Map2k3 gene was upregulated. Map2k5 acts as a scaffold for the formation of a ternary 
MAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex (http://www.genecards.org/cgi-
bin/carddisp.pl?gene=MAP2K5). The Map2k3 gene has a MAP kinase kinase activity [45-46] 
and involved in the regulation of the cytokine biosynthetic process [47]. Map2k3 phosphorylates, 
and thus activates, MAPK14/p38-MAPK. This kinase can be stimulated by insulin [48] and by 
cytokine treatment in human islets and in a mouse beta cell line [49]. Several genes that activate 
the MAPK activity and the MAPKKK cascade were also upregulated by HA: Gadd45b, Pxn, 
Map2k3, Met, Mapkapk3, Avp1, Spag9, and Ppm1 (Table2).  MAPK signaling cascades, in 
mammals, regulate important cellular processes such as gene expression, cell proliferation, cell 
survival and death.  Transcription factors are important MAPK targets and that the genes that are 
regulated in response to MAPKs may be defined by DNA microarray [50].  HA-treatment caused 
a 3-fold increase in the expression of Map2k3 gene compared to the control.  P38 MAPK 
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signaling cascade has been suggested to activate melanogenesis by activating Mitf [51-52] The 
decrease in the expression of Map2k5 gene, revealed by the microarray results,  suggests the 
inhibition of the mitogen-activated protein kinase (MAPK) activity (Table 1). Results of the  
determination of the expression of the activation of pERK1/2 revealed an activation of ERK1/2 
(data not shown).  We have previously reported that pERK1/2 expression was increased by T. 
hirsuta extract treatment [53] verifying our previous findings. 
The effect of HA on B16 cells was compared with that of the untreated cells (control), α-
MSH and Rp-cAMPS.  α-MSH stimulates melanogenesis by activating the MC1 receptor (MC1-
R) on melanocytes and causes an increase in the dendricity of melanocytes [54-55], while Rp-
cAMPS inhibits melanogenesis through its cAMP antagonistic action [32].  The observed effect 
of α-MSH was not as significant as HA but this could be attributed to the presence of the serum 
in the medium which could have had a masking effect, as the addition of 200 nm α-MSH was 
enough to increase the cAMP level significantly. Validation of the DNA microarray results using 
quantitative rt-PCR showed an observed high correlation between quantitative gene expression 
values and microarray platform results (Figure 2a-2d).  Rt-PCR supports the use of microarray 
platforms for the quantitative characterization of gene expression [56].   
The increase in the expression of the Gadd45b gene prompted us to determine the 
expression its upstream, the melanoma differentiation-associated 7 (Mda-7) gene. Recently, the 
Mda-7  or interleukin 24 (mda-7/IL-24) gene has been recognized to have a potential as an 
anticancer gene, and has been the focus of some groups doing cancer research. We determined 
the effect of HA on the expression of the Mda-7 gene in both mouse and human melanoma cells 
and compared it with its effect on the human epidermal melanocyte.  Results show that HA 
significantly increased the expression of Mda-7 gene in both mouse and human melanoma cells 
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and in human epidermal melanocytes (Figure 3).  It has been reported that a noteworthy aspect of 
mda-7/IL-24 as a cancer therapeutic is its ability to selectively kill cancer cells without harming 
normal cells [57].  
The increase in the expression of the Mda-7 gene has been reported to occur after the 
induction of irreversible growth arrest and terminal differentiation in human melanoma cells 
treated with recombinant human fibroblast interferon [26, 58].  Here, HA-treated cells exhibited 
dendricity (Fig. 4), which is a distinctive feature of cell differentiation. Dendrite formation in 
melanocytes requires actin polymerization in the newly forming dendrite, and dendrite formation 
in melanocyte is stimulated by hormones and ultraviolet light [53]. Dendricity has been 
established as a hallmark of cell differentiation in melanocytes [21,59]. HA treatment caused the 
B16 melanoma cell differentiation, as shown by the F-actin stained cells (Figure 4).  HA-treated 
cells had more dendritic extensions than the control or MSH-treated cells due to a changed F-
actin polymerization.  Moreover, like melanocytes, HA-treated cells appeared to be scattered, 
and not clumped together as observed in control cells.  The appearance of the HA-treated cells is 
similar to that of the melanocytes in the skin.  In a related study, Edgar and Bennett [60]reported 
that inhibition of Myosin VA inhibited the formation of dendrites by melanocytes. Here, Myosin 
VA was inhibited (Table 1) but dendricity was stimulated in the B16 cells. Melanocytes are 
known to be dendritic and are scattered in the basal layer of the epidermis [61]. It is also 
interesting to note that while dendricity is usually observed in α-MSH-treated cells due to cAMP 
upregulation of dendrite formation, HA decreased the expression of the Mc1r gene, the cAMP 
pathway receptor, but still was able to cause an increase in dendrite formation (Figure 5a and 5b).  
Usually, dendrite formation is a rapid process preceding tyrosinase protein expression and 
melanosome relocalization [14].  In stationary spread cells, expanding circular F-actin-containing 
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structures were found to be associated with cell shape changes and reorganization of the actin 
cytoskeleton [62].  Our data shows that the observed dendritic morphology following HA 
treatment, was most likely due to the enhanced expressions of genes associated with the 
cytoskeleton (Pxn) and cell differentiation (Gadd45b).  In general, the extent of dendricity of 
melanocytes correlates directly with their melanogenic activity.  Melanocytic dendrites are 
microtubule-containing structures and their extension is regulated by a number of growth factors, 
including α-MSH, ET-1, and NGF, as well as by UVR [63].  Indirectly, Mc1r inhibition will 
cause a decrease in melanocyte dendricity as the inhibition of the Mc1r function induces 
melanocytes to switched into their pheomelanogenic mode which means an inhibition of the 
expression of all known melanosomal proteins to basal levels, except for tyrosinase [64,65].  
Decreased melanogenesis would mean less melanosome to transport  through the cell dendritic 
extensions.  
 
HA activated the genes that are intermediates of  the MAPK cascade and promoted Il-
24/Mda-7 gene expression leading to decreased Mitf gene expression and increased cell 
dendricity, respectively.  The downregulation of the Mitf gene expression was through the 
inhibition of the two signaling pathways involved in melanogenesis – the MAPK pathway, and 
the cAMP pathway, through the downregulation of the Mc1r gene expression. This study 
demonstrated that HA causes Mitf inhibition by reducing the expressions of MAPKK 
intermediates.  As expected, the downregulation of Mitf expression caused a decrease in the 
expressions of Mc1r and melanosome transport genes. It was also observed that the inhibition of 
the Mc1r gene only caused a partial decrease in Mitf gene expression (Fig. 5c), which means that 
the inhibition of the MAPK pathway also contributed to the overall downregulation of the Mitf 
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gene following HA treatment. For the change in the cell morphology, genes that are observed to 
be expressed by differentiating cells, as well as the melanoma differentiation-associated gene 
(Mda-7), were upregulated, and confirms that the cell differentiation effects of HA is 
independent of its melanogenesis regulatory effects.  HA, a daphnane-type diterpene like known 
cell differentiation agenes -retinoic acid and mezerein, is not just a novel melanogenesis inhibitor 
but also as a cell differentiation agent that also has potential for use in therapy or  management of 
melanoma. 
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Table 1.  List of differentially regulated genes in in hirsein A (HA)-, α –MSH- and Rp-cAMPS- 
treated B16 murine melanoma cells  ( ≤  - 0.5 log) as determined by DNA microarray.  
Gene 
symbol 
Gene Name Biological Process 
Log gene expression
a
 
(Treated/Control) 
α -MSH 
Rp-
cAMPS 
HA 
Mitf microphthalmia-
associated 
transcription factor 
Cell differentiation, melanocyte 
differentiation, negative regulation 
of apoptosis, pigmentation, 
regulation of transcription, Wnt 
receptor signaling pathway 
0.40 -0.03 -3.68 
Rab27a RAB27A, member 
RAS oncogene 
family 
Melanosome transport, melanocyte 
differentiation,  
-0.18 -0.12 -2.2 
 
Sorbs3 
sorbin and SH3 
domain containing 
3 
Cell adhesion, negative regulation of 
transcription from RNA polymerase 
II promoter,  positive regulation of 
MAPKKK cascade 
0.26 0.18 -2.08 
Mc1r Melanocortin 1 
receptor 
Melanin biosynthetic process, 
intracellular protein kinase cascade, 
positive regulation of protein kinase 
A and protein kinase C signaling 
cascade  
0.27 -0.03 -1.76 
Mlph Melanophilin Intracellular protein transport, 
melanocyte differentiation, 
melanosome localization, 
pigmentation 
-0.20 -0.05 -1.52 
Ldb1 
 
LIM domain 
binding 1 
Regulation of transcription, Wnt 
receptor signaling pathway 
0.09  0.10 -0.62 
Myo7a Myosin VIIa Actin filament-based movement, 
ATP catabolic process, melanosome 
transport 
0.25 0.17 -0.86 
Mreg melanoregulin Developmental pigmentation, 
melanocyte differentiation, 
pigmentation 
0.00 -0.16 -0.65 
 
Agt 
angiotensinogen 
(serpin peptidase 
inhibitor, clade 
G-protein coupled receptor protein 
signaling pathway, Activation of 
phospholipase C activity 
-0.23 -0.02 -0.57 
Map2k5 mitogen-activated 
protein kinase 
kinase 5 
MAPKKK cascade, positive 
regulation of cell growth and 
epithelial cell proliferation 
-0.01 0.16 -0.52 
Prkar2b protein kinase, 
cAMP dependent 
regulatory, type II 
beta 
Cell proliferation, regulation of 
protein kinase activity and protein 
phosphorylation, signal transduction 
-0.48 -0.20 -0.50 
a
Data is shown as signal log2 ratio to control 
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Table 2.  List of differentially upregulated genes in in hirsein A (HA)-, α –MSH- and 
Rp-cAMPS- treated B16 murine melanoma cells  (≥ 0.5 log) as determined 
by DNA microarray. 
Gene 
symbol 
Gene Name Biological Process 
Log gene expression
a
 
(Treated/Control) 
α -
MSH 
Rp-
cAMPS 
HA 
Ppap2b  phosphatidic 
acid phosphatase 
type 2B 
Phospholipid metabolism, blood 
vessel development, Regulation of 
Wnt receptor signaling pathway, 
positive regulation of transcription 
factor activity 
 
nd
b
 nd 3.65 
Gadd45b  growth arrest 
and DNA-
damage-
inducible 45 beta 
Activation of MAPKK activity, 
apoptosis, cell differentiation, 
negative regulation of protein 
kinase activity, regulation of cell 
cycle 
nd  nd 2..85 
Pxn  Paxillin Activation of MAPK activity, cell 
adhesion, cytoskeleton 
organization, lamellipodium 
assembly,  
nd nd 2.35 
Map2k3  mitogen-
activated protein 
kinase kinase  
, Activation of MAPK activity, 
MAPKKK cascade, regulation of 
cytokine biosynthetic process, 
protein phosphorylation,cell 
proliferation and differentiation 
0.42 0.13 2.13 
Wisp1  WNT1 inducible 
signaling 
pathway protein 
1 
Cell adhesion, regulation of cell 
growth, Wnt receptor signaling 
pathway 
nd nd 1.26 
Prkx  protein kinase, 
X-linked 
Protein phosphorylation 0.4 0.22 1.49 
Met  met proto-
oncogene 
(hepatocyte 
growth factor) 
Activation of MAPK activity, 
positive regulation of dendrite 
morphogenesis 
1.13 -0.09 1.3 
Gclc  glutamate-
cysteine ligase, 
catalytic subunit 
Positive regulation of protein 
ubiquitination, glutathione 
metabolic process and biosynthetic 
process 
0.23 0.00 1.42 
Creb3l2  cAMP-
responsive 
element binding 
protein 3-like 2 
Regulation of DNA-dependent 
transcription, regulation of 
transcription 
-0.07 0.06 1.29 
Shc1  src homology 2 Cell-cell adhesion, intracellular nd 0.06 1.26 
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domain-
containing 
transforming 
signaling pathway, neuron 
differentiation, regulation of growth  
Kremen1  kringle 
containing 
transmembrane 
protein 1 
Wnt receptor signaling pathway nd nd 1.01 
Mapkapk
3 
mitogen-
activated protein 
kinase-activated 
protein kinase 3 
Protein Phosphorylation      nd        nd 1.02 
Avpi1 arginine 
vasopressin-
induced 1 
Activation of MAPK activity, cell 
cycle 
0.69 0.12 0.99 
Senp2 SUMO/sentrin 
specific 
peptidase 2 
mRNA transport, Wnt receptor 
signaling pathway  
0.03 -0.27 0.90 
Spag9 sperm associated 
antigen 9 
Activation of JUN kinase activity, 
MAPK activity 
0.23 0.05 0.76 
Cno cappuccino Melanosome organization 0.00 -0.05 0.70 
Kif2a/Kn
s2 
kinesin family 
member 2A 
Cell cycle, cell differentiation, cell 
division, microtubule-based 
movement, mitosis 
nd 0.10 0.67 
Csnk1a1 casein kinase 1, 
alpha 1 
Cell cycle, cytoskeleton, cell 
division, cell morphogenesis,  Wnt 
receptor signaling pathway, mitosis 
0.05 -0.01 0.66 
Atf4 activating 
transcription 
factor 4 
Positive regulation of transcription 
from RNA polymerase II promoter 
0.35 0.07 0.64 
Ppm1l protein 
phosphatase 1 
(formerly 2C)-
like 
MAPKKK cascade, Protein 
dephosphorylation, transmembrane 
receptor protein serine/threonine 
kinase signaling pathway,  
nd nd 0.59 
Adcy7 adenylate 
cyclase 7 
Activation of adenylate cyclase 
activity, cAMP biosynthetic 
process, intracellular signaling 
pathway,  
nd nd 0.57 
Csnk2b casein kinase 2, 
beta polypeptide 
Regulation of catalytic activity, 
regulation of phosphorylation, Wnt 
receptor signaling pathway  
0.16 0.01 0.55 
Axin1 Axin 1 Apoptosis, Wnt receptor signaling 
pathway, cytoplasmic microtubule 
organization 
-0.07 0.13 0.55 
a
Data is shown as signal log2 ratio to control 
b
 nd – not detected  
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Figure Legends  
 
Fig.1 Gene expression map of 33 genes that were differentially expressed in B16 melanoma cells 
treated with hirsein A (HA), α-MSH, or Rp-cAMPS.  The microarray chip was loaded with 265 
genes for  melanogenesis, melanosome transport, tyrosine kinase, cell signal transduction. The 
33 genes subjected to hierarchical clustering were chosen as having a log of -0.5 or lower (the 
ratio between HA and untreated control) for the downregulated genes and 0.5 or higher (the ratio 
between HA and untreated control) for the upregulated genes.  Horizontal stripes represent genes 
and columns show experimental samples. Clustering was performed on genes  using the 
euclidian distance method. Red and green color codes for up- and downregulation, respectively.  
  
Fig.2 Effect of hirsein A (HA) on the expression of the genes for (a) melanogenesis regulation - 
microphthalmia-associated transcription factor (Mitf) and melanocortin 1 receptor (Mc1r),  (b) 
melanosome transport - Rab27a, melanophilin (Mlph), and Myosin Va (Myo5a), (c) sorbin and 
SH3 domain containing 3 (Sorbs3) gene, and (d) upregulated genes in B16 cells.  B16 cells were 
seeded at a density of 3×10
6
 cells per 100-mm dish.  After overnight incubation, the cells were 
treated with or without 25  μM Rp-cAMPS, 0.2 μmol/L α–MSH, 1 μM hirsein A (HA) for 4 h,  
after which, RNA isolation and then reverse transcription PCR was carried out to obtain cDNAs 
that were used for real-time PCR. Results represent the mean ± S.D. of three independent 
experiments.  * Statistically significant (P< 0.05) difference between control and treated cells.   
 
Fig. 3.   Effect of hirsein A (HA) on the expression of melanoma differentiation gene-7 (Mda-7) 
in B16 melanoma cells (B16), HMV-II melanoma cells (HMV-II), and human epithelial 
melanocytes (HEM).  Cells were seeded at a density of 3×10
6
 cells per 100-mm dish.  After 
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overnight incubation, the cells were treated with or without 0.2 μM α–MSH or  1 μM hirsein A 
(HA) for 4 h after which RNA isolation and then reverse transcription PCR was carried out to 
obtain cDNAs that were used for real-time PCR. Results represent the mean ± S.D. of three 
independent experiments. * Statistically significant (P< 0.05) difference between control and 
treated cells.  
 
Fig. 4.   F-actin polymerization in B16 murine melanoma cells. B16 cells were seeded onto four-
well chamber slides at 4 × 10
4
 cells per well. After overnight incubation, the cells were treated 
with or without 0.2 μM alpha melanocyte stimulating hormone (α–MSH) or 1 μM hirsein A (HA) 
for 24 h. The cells were stained with rhodamine-phalloidin for the actin cytoskeleton (left panels) 
and with DAPI for the nuclei (middle panels). Merged images are shown in the right panels. All 
photographs were taken at 200×  magnification.  Each bar represents 20 µm.  
 
 
Fig.5. The effect of hirsein A (HA) on the  (a) cell morphology (b) Mc1r mRNA and (c) Mitf 
mRNA expression of B16 murine melanoma cells transfected with Mc1r siRNA.  B16 cells were 
seeded into 6-well plates at a density of 1×10
5
 cells per well, and the next day cells were 
transfected with Negative control siRNA or Mc1r siRNA complexed with Lipofectamine 
RNAiMAX (Invitrogen). After 24 h of incubation, control cells were left untreated (transfection 
reagent alone), or treated with 200 nM α-MSH or 1 µM hirsein A (HA) and incubated further for 
4 h prior  to RNA extraction.  Images were taken using Leica DM1L microscope camera.  
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